Dr. Merat N. Karbasian-Esfahani

Mauna Pandya is a Hematologist and an Oncologist in Chicago Ridge, Illinois. Dr. Pandya is rated as a Distinguished provider by MediFind in the treatment of Alpha Thalassemia X-Linked Intellectual Disability Syndrome. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Severe Congenital Neutropenia, Thrombocytopenia, and Bone Marrow Aspiration.

“Medical oncology has been the fastest-growing field for the last two decades. It satisfied my passion for scientific growth and provided me a venue for giving back to humanity and serving those in need while fulfilling my dreams. I love people and the interactions with families. I believe in a patient-based approach and educating patients so they can make the best decisions for themselves. I am here to support my patients while they are fighting cancer.”. Dr. Tajuddin is rated as a Distinguished provider by MediFind in the treatment of Alpha Thalassemia X-Linked Intellectual Disability Syndrome. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Paget Disease of the Breast, and Colorectal Cancer.

The diagnosis of cancer is associated with extreme anxiety and concern about the future. I feel honored to be given the opportunity to care for my patients in one of the most difficult times in their lives and help them navigate their diagnosis and treatment options. My philosophy of care revolves around effective communication with my patients, empowering them with the knowledge about their diagnosis and helping them decide the treatment approach that best suits them. Oncology is a rapidly growing field and I take delight in learning about the research of the latest treatments being used in cancer management and sharing that with my patients. I admire my patients’ endurance and resilience and cherish the relationships I develop along the way. Dr. Syed is rated as an Advanced provider by MediFind in the treatment of Alpha Thalassemia X-Linked Intellectual Disability Syndrome. His top areas of expertise are Breast Cancer, WT1-Related Wilms Tumor Syndromes, Chromophobe Renal Cell Carcinoma, and Wilms Tumor.